Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Acute Myeloid Leukemia market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Acute Myeloid Leukemiamarket, defines the market attractiveness level of Acute Myeloid Leukemia market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Acute Myeloid Leukemia industry, describes the types of Acute Myeloid Leukemia market, the applications of major players and the market size, and deeply analyzes the current situation of the global Acute Myeloid Leukemia market and the development prospects and opportunities of Acute Myeloid Leukemia industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Acute Myeloid Leukemia market in Chapter 13.
By Player:
Eisai
CTI Biopharma Corp
Sunesis Pharmaceuticals
Genzyme Corporation
Clavis Pharma
Astellas Pharma
Cephalon
Celgene Corporation
Abbvie
By Type:
Chemotherapy
Radiation Therapy
Stem Cell Transplant
Targeted Therapy
Others
By End-User:
Hospital
Retails Drug Stores
Ambulatory Care Centers
Oncology Centers
Clinics
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Acute Myeloid Leukemia Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Acute Myeloid Leukemia Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Acute Myeloid Leukemia Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Acute Myeloid Leukemia Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Acute Myeloid Leukemia Market Analysis and Outlook to 2022
-
7.1 Global Acute Myeloid Leukemia Consumption (2017-2022)
-
7.2 United States Acute Myeloid Leukemia Consumption (2017-2022)
-
7.3 Europe Acute Myeloid Leukemia Consumption (2017-2022)
-
7.4 China Acute Myeloid Leukemia Consumption (2017-2022)
-
7.5 Japan Acute Myeloid Leukemia Consumption (2017-2022)
-
7.6 India Acute Myeloid Leukemia Consumption (2017-2022)
-
7.7 South Korea Acute Myeloid Leukemia Consumption (2017-2022)
8 Region and Country-wise Acute Myeloid Leukemia Market Analysis and Outlook to 2028
-
8.1 Global Acute Myeloid Leukemia Consumption Forecast (2022-2028)
-
8.2 United States Acute Myeloid Leukemia Consumption Forecast (2022-2028)
-
8.3 Europe Acute Myeloid Leukemia Consumption Forecast (2022-2028)
-
8.4 China Acute Myeloid Leukemia Consumption Forecast (2022-2028)
-
8.5 Japan Acute Myeloid Leukemia Consumption Forecast (2022-2028)
-
8.6 India Acute Myeloid Leukemia Consumption Forecast (2022-2028)
-
8.7 South Korea Acute Myeloid Leukemia Consumption Forecast (2022-2028)
9 Global Acute Myeloid Leukemia Market Outlook by Types and Applications to 2022
-
9.1 Global Acute Myeloid Leukemia Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Chemotherapy Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Radiation Therapy Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Stem Cell Transplant Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Targeted Therapy Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Acute Myeloid Leukemia Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Retails Drug Stores Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Ambulatory Care Centers Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Oncology Centers Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Clinics Consumption and Growth Rate (2017-2022)
10 Global Acute Myeloid Leukemia Market Outlook by Types and Applications to 2028
-
10.1 Global Acute Myeloid Leukemia Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Radiation Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Stem Cell Transplant Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Acute Myeloid Leukemia Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Retails Drug Stores Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Ambulatory Care Centers Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Oncology Centers Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
11 Global Acute Myeloid Leukemia Import and Export Analysis (Top 5 Countries)
-
11.1 Global Acute Myeloid Leukemia Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Acute Myeloid Leukemia Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Acute Myeloid Leukemia Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Acute Myeloid Leukemia Market Competitive Analysis
-
14.1 Eisai
-
14.1.1 Eisai Company Details
-
14.1.2 Eisai Acute Myeloid Leukemia Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Eisai Acute Myeloid Leukemia Product and Service
-
14.2 CTI Biopharma Corp
-
14.2.1 CTI Biopharma Corp Company Details
-
14.2.2 CTI Biopharma Corp Acute Myeloid Leukemia Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 CTI Biopharma Corp Acute Myeloid Leukemia Product and Service
-
14.3 Sunesis Pharmaceuticals
-
14.3.1 Sunesis Pharmaceuticals Company Details
-
14.3.2 Sunesis Pharmaceuticals Acute Myeloid Leukemia Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Sunesis Pharmaceuticals Acute Myeloid Leukemia Product and Service
-
14.4 Genzyme Corporation
-
14.4.1 Genzyme Corporation Company Details
-
14.4.2 Genzyme Corporation Acute Myeloid Leukemia Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Genzyme Corporation Acute Myeloid Leukemia Product and Service
-
14.5 Clavis Pharma
-
14.5.1 Clavis Pharma Company Details
-
14.5.2 Clavis Pharma Acute Myeloid Leukemia Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Clavis Pharma Acute Myeloid Leukemia Product and Service
-
14.6 Astellas Pharma
-
14.6.1 Astellas Pharma Company Details
-
14.6.2 Astellas Pharma Acute Myeloid Leukemia Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Astellas Pharma Acute Myeloid Leukemia Product and Service
-
14.7 Cephalon
-
14.7.1 Cephalon Company Details
-
14.7.2 Cephalon Acute Myeloid Leukemia Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Cephalon Acute Myeloid Leukemia Product and Service
-
14.8 Celgene Corporation
-
14.8.1 Celgene Corporation Company Details
-
14.8.2 Celgene Corporation Acute Myeloid Leukemia Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Celgene Corporation Acute Myeloid Leukemia Product and Service
-
14.9 Abbvie
-
14.9.1 Abbvie Company Details
-
14.9.2 Abbvie Acute Myeloid Leukemia Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Abbvie Acute Myeloid Leukemia Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Acute Myeloid Leukemia
-
Figure Acute Myeloid Leukemia Picture
-
Table Global Acute Myeloid Leukemia Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Acute Myeloid Leukemia Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Acute Myeloid Leukemia Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Acute Myeloid Leukemia Consumption by Country (2017-2022)
-
Figure United States Acute Myeloid Leukemia Consumption and Growth Rate (2017-2022)
-
Table Europe Acute Myeloid Leukemia Consumption and Growth Rate (2017-2022)
-
Figure China Acute Myeloid Leukemia Consumption and Growth Rate (2017-2022)
-
Figure Japan Acute Myeloid Leukemia Consumption and Growth Rate (2017-2022)
-
Figure India Acute Myeloid Leukemia Consumption and Growth Rate (2017-2022)
-
Figure South Korea Acute Myeloid Leukemia Consumption and Growth Rate (2017-2022)
-
Figure Global Acute Myeloid Leukemia Consumption Forecast by Country (2022-2028)
-
Figure United States Acute Myeloid Leukemia Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Acute Myeloid Leukemia Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Acute Myeloid Leukemia Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Acute Myeloid Leukemia Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Acute Myeloid Leukemia Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Acute Myeloid Leukemia Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chemotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Radiation Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Stem Cell Transplant Consumption and Growth Rate (2017-2022)
-
Figure Global Targeted Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Retails Drug Stores Consumption and Growth Rate (2017-2022)
-
Figure Global Ambulatory Care Centers Consumption and Growth Rate (2017-2022)
-
Figure Global Oncology Centers Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Radiation Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Stem Cell Transplant Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retails Drug Stores Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ambulatory Care Centers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oncology Centers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Acute Myeloid Leukemia Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Acute Myeloid Leukemia Export by Region (Top 5 Countries) (2017-2028)
-
Table Eisai (Foundation Year, Company Profile and etc.)
-
Table Eisai Acute Myeloid Leukemia Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eisai Acute Myeloid Leukemia Product and Service
-
Table CTI Biopharma Corp (Foundation Year, Company Profile and etc.)
-
Table CTI Biopharma Corp Acute Myeloid Leukemia Sales, Price, Value and Gross Profit (2017-2022)
-
Table CTI Biopharma Corp Acute Myeloid Leukemia Product and Service
-
Table Sunesis Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Sunesis Pharmaceuticals Acute Myeloid Leukemia Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sunesis Pharmaceuticals Acute Myeloid Leukemia Product and Service
-
Table Genzyme Corporation (Foundation Year, Company Profile and etc.)
-
Table Genzyme Corporation Acute Myeloid Leukemia Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genzyme Corporation Acute Myeloid Leukemia Product and Service
-
Table Clavis Pharma (Foundation Year, Company Profile and etc.)
-
Table Clavis Pharma Acute Myeloid Leukemia Sales, Price, Value and Gross Profit (2017-2022)
-
Table Clavis Pharma Acute Myeloid Leukemia Product and Service
-
Table Astellas Pharma (Foundation Year, Company Profile and etc.)
-
Table Astellas Pharma Acute Myeloid Leukemia Sales, Price, Value and Gross Profit (2017-2022)
-
Table Astellas Pharma Acute Myeloid Leukemia Product and Service
-
Table Cephalon (Foundation Year, Company Profile and etc.)
-
Table Cephalon Acute Myeloid Leukemia Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cephalon Acute Myeloid Leukemia Product and Service
-
Table Celgene Corporation (Foundation Year, Company Profile and etc.)
-
Table Celgene Corporation Acute Myeloid Leukemia Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celgene Corporation Acute Myeloid Leukemia Product and Service
-
Table Abbvie (Foundation Year, Company Profile and etc.)
-
Table Abbvie Acute Myeloid Leukemia Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbvie Acute Myeloid Leukemia Product and Service
-
